OCRA Joins Coalition Working to Expand Genetic Testing Access
OCRA recently joined the Inter-Organization Cancer Genetics Clinical Evidence Coalition (INTERACT), which is working to ensure genetic testing access for all who may carry inherited mutations that increase the risk of ovarian and other cancers. The coalition, which includes patient advocacy and industry members, endeavors to drive changes in cancer-related genetic testing policies to expand … Continued